Allendale, 7401, NJ,
United States
Progenitor Cell Therapy Technographics
Progenitor Cell Therapy Technographics, Software Purchases, AI and Digital Transformation Initiatives
Discover the latest software purchases and digital transformation initiatives being undertaken by Progenitor Cell Therapy and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 100 Progenitor Cell Therapy employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.
During our research, we have identified that Progenitor Cell Therapy has purchased the following applications: Oracle NetSuite ERP for ERP Financial in 2014, Microsoft 365 for Collaboration in 2015, HubSpot CMS for Web Content Management in 2021 and the related IT decision-makers and key stakeholders.
Our database provides customer insight and contextual information on which enterprise applications and software systems Progenitor Cell Therapy is running and its propensity to invest more and deepen its relationship with Oracle , Microsoft , HubSpot or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.
We have been analyzing Progenitor Cell Therapy revenues, which have grown to $10.0 million in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Progenitor Cell Therapy intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.
Progenitor Cell Therapy Tech Stack and Enterprise Applications
Progenitor Cell Therapy ERP
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Oracle | Legacy | Oracle NetSuite ERP | ERP Financial | ERP | n/a | 2014 | 2014 |
In 2014, Progenitor Cell Therapy implemented Oracle NetSuite ERP. The cloud-hosted Oracle NetSuite ERP deployment was scoped to address core ERP Financial requirements for the company, providing a centralized platform for accounting and finance operations within the Communications industry.
The implementation configured core ERP Financial modules including general ledger, accounts payable, accounts receivable, fixed assets, billing and financial reporting. Standard finance workflows were established to support order-to-cash billing and procure-to-pay invoice processing, with chart of accounts design, period close routines and role-based access controls configured for finance and accounting users.
Oracle NetSuite ERP was provisioned to serve corporate finance, accounting and procurement functions across the United States, aligning transaction processing with revenue and invoice management processes. Governance focused on centralized financial controls, defined month-end close workflows and standardized financial data models to support consistent reporting and auditability.
|
Progenitor Cell Therapy Collaboration
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Microsoft | Legacy | Microsoft 365 | Collaboration | Collaboration | n/a | 2015 | 2015 |
In 2015 Progenitor Cell Therapy implemented Microsoft 365. Progenitor Cell Therapy uses Microsoft 365 for Collaboration to support corporate communications and productivity functions across its United States operations and an employee base of roughly 100.
The Microsoft 365 implementation leverages core collaboration capabilities including Exchange Online email, SharePoint Online intranet and document management, OneDrive for Business file synchronization, and Microsoft Teams for messaging and meetings, configured with centralized identity and administrative controls and policy driven governance for data retention and external sharing. Operational coverage focuses on communications and knowledge worker business functions, with IT administration responsible for user provisioning, group based access controls, and tenant level configuration to enforce security and compliance settings.
|
Progenitor Cell Therapy Content Management
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| HubSpot | Legacy | HubSpot CMS | Web Content Management | Content Management | n/a | 2021 | 2021 |
In 2021, Progenitor Cell Therapy implemented HubSpot CMS as its Web Content Management solution for its public website. The HubSpot CMS deployment centralized content administration for the corporate site at https://www.pctcelltherapy.com, supporting the communications and marketing function within the United States organization. The implementation established a single platform for publishing corporate pages and campaign landing pages, aligning content delivery with marketing workflows and stakeholder review cycles.
HubSpot CMS is configured with template based page management, a visual content editor, content staging and publishing workflows, SEO and metadata controls, and an assets repository to manage images and documents. Governance is handled by the marketing and communications teams through role based editorial permissions and staged approvals to support compliance review of regulated messaging. As the company Web Content Management platform, HubSpot CMS serves as the primary system for site pages, blog content, landing pages, and contact capture points, enabling marketing operations to manage ongoing content updates and campaign coordination.
|
Progenitor Cell Therapy CRM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
CRM | CRM |
|
2015 | 2015 |
|
|
|
|
|
Marketing Automation | CRM |
|
2015 | 2015 |
|
Progenitor Cell Therapy IaaS
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Application Hosting and Computing Services | IaaS |
|
2015 | 2015 |
|
|
|
|
|
Application Hosting and Computing Services | IaaS |
|
2020 | 2020 |
|
|
|
|
|
Content Delivery Network | IaaS |
|
2020 | 2020 |
|
IT Decision Makers and Key Stakeholders at Progenitor Cell Therapy
| First Name | Last Name | Title | Function | Department | Phone | |
|---|---|---|---|---|---|---|
| Executive Chairman | CXO | Finance | ||||
| President & Chief Scientific Officer | CXO | Finance | ||||
| Vice President Engineering & Innovation | VP | R&D |
Apps Being Evaluated by Progenitor Cell Therapy Executives
| Date | Company | Status | Vendor | Product | Category | Market |
|---|---|---|---|---|---|---|
| No data found | ||||||